FACA Fundamental Analysis - FIGURE ACQUISITION CORP I -A

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to FACA. FACA was compared to 0 industry peers in the Unkown industry. FACA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FACA does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

FACA had positive earnings in the past year.

In the past year FACA has reported a negative cash flow from operations.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	4.25%
ROE	4.43%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for FACA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

FACA has more shares outstanding than it did 1 year ago.

FACA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 21.30 indicates that FACA is not in any danger for bankruptcy at the moment.

FACA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	21.3

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

FACA has a Current Ratio of 0.57. This is a bad value and indicates that FACA is not financially healthy enough and could expect problems in meeting its short term obligations.

FACA has a Quick Ratio of 0.57. This is a bad value and indicates that FACA is not financially healthy enough and could expect problems in meeting its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	0.57
Quick Ratio	0.57

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

FACA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28485.06%, which is quite impressive.

EPS 1Y (TTM)28485.06%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-46.08%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

FACA is valuated quite expensively with a Price/Earnings ratio of 33.47.

Compared to an average S&P500 Price/Earnings ratio of 26.57, FACA is valued a bit more expensive.

		Industry Rank	Sector Rank
PE	33.47
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for FACA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

FIGURE ACQUISITION CORP I -A

NYSE:FACA (12/29/2022, 8:04:01 PM)

10.04

-0.01 (-0.1%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.27%

Inst Owner Change0%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap412.36M

Revenue(TTM)N/A

Net Income(TTM)12.30M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	33.47
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	1.48
P/tB	1.48
EV/EBITDA	N/A

EPS(TTM)0.3

EY2.99%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.02

FCFYN/A

OCF(TTM)-0.02

OCFYN/A

SpS0

BVpS6.77

TBVpS6.77

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	4.25%
ROE	4.43%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.57
Quick Ratio	0.57
Altman-Z	21.3

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)28485.06%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-46.08%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-7771.6%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

FIGURE ACQUISITION CORP I -A / FACA FAQ

Can you provide the ChartMill fundamental rating for FIGURE ACQUISITION CORP I -A?

ChartMill assigns a fundamental rating of 2 / 10 to FACA.

What is the valuation status for FACA stock?

ChartMill assigns a valuation rating of 3 / 10 to FIGURE ACQUISITION CORP I -A (FACA). This can be considered as Overvalued.

How profitable is FIGURE ACQUISITION CORP I -A (FACA) stock?

FIGURE ACQUISITION CORP I -A (FACA) has a profitability rating of 1 / 10.

What is the financial health of FIGURE ACQUISITION CORP I -A (FACA) stock?

The financial health rating of FIGURE ACQUISITION CORP I -A (FACA) is 2 / 10.

FIGURE ACQUISITION CORP I -A (FACA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

FIGURE ACQUISITION CORP I -A / FACA FAQ

Can you provide the ChartMill fundamental rating for FIGURE ACQUISITION CORP I -A?

What is the valuation status for FACA stock?

How profitable is FIGURE ACQUISITION CORP I -A (FACA) stock?

What is the financial health of FIGURE ACQUISITION CORP I -A (FACA) stock?